Group structure
3 companies in 2 countries
United Kingdom1
Headquarters not stated1
Groups are put together by Prognia from the names regulators publish and from company links; they are not an official corporate structure.
Medicines
Every medicine of every company in the group, current ones first.
11 medicines
| Medicine | Substance | Country | Status | Authorised |
|---|---|---|---|---|
| anastrozol | Anastrozole | Brazil | Authorised | 2025 |
| cloridrato de erlotinibe | Erlotinib | Brazil | Authorised | 2025 |
| CLORIDRATO DE LIDOCAINA | Lidocaine | Brazil | Authorised | 2026 |
| DIXMABIO | Sugammadex | Brazil | Authorised | 2026 |
| EMNYRA | Teriflunomide | Brazil | Authorised | 2025 |
| ETORICOXIBE | Etoricoxib | Brazil | Authorised | 2025 |
| Ixobam | Apixaban | Brazil | Authorised | 2025 |
| lacosamida | Lacosamide | Brazil | Authorised | 2025 |
| LUNIERA | Vildagliptin | Brazil | Authorised | 2025 |
| rivaroxabana | Rivaroxaban | Brazil | Authorised | 2025 |
| BIONIX2.25 % + 2.25 % · Liquid | Alkyl dimethyl ethylbenzyl ammonium, Benzalkonium | Canada | Cancelled |